David M. Smadja

Professor
Université Paris Cité, INSERM U1140, Innovative Therapies in Haemostasis, France

Presentation(s):

• PB0056 - Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0083 - Platelet activation and COVID-19 mortality: insights from coagulopathy, antiplatelet therapy and inflammation

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0585 - Prognostic value of troponin elevation at admission and during monitoring in COVID-19 patients

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0954 - Thrombotic profile according to antithombin deficiency and SERPINC1 gene analysis: a French retrospective cohort study.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM